Community Academic Profiles

Lei Xing

Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer

Contact Information

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Simon Wu (650) 725-8231
To view all clinical trials at Stanford, please see the Clinical Trials Directory.

Brief

To determine if a new optical system that can track a patient's movement during treatment can be used to measure motion and allow for motion adjustments in order to decrease the amount of healthy tissue that receives radiation without limiting our ability to cure cancers using radiation.

Recruiting Status:

Recruiting

Stanford Recruiting Status:

Recruiting

Condition(s):

Intervention(s):

  • Procedure: Radiotherapy (Standard of care)
  • Procedure: 4.1.2 Intrafraction monitoring with EPIC based MV/KV imaging (Standard of care)
  • Procedure: 4.1.3 Intrafraction monitoring with AlignRT

Phase:

N/A

Eligibility

Ages Eligible for Study:

18 years to Any Age

Genders Eligible for Study:

Male and Female

Health of Volunteers:

People with the conditions listed in this trial can participate as controls.

Key Inclusion Criteria:

- Patients with HNC undergoing radiation therapy at Stanford University

- Age >= 18 years old

- Radiation course >= 4 weeks duration

- Ability to understand and the willingness to sign a written informed consent document.


Key Exclusion Criteria:

- Factors such as claustrophobia inhibiting use of thermoplastic mask immobilization device.

- Patients who are pregnant or nursing, which preclude them from undergoing active radiation treatment.

Additional Study Details

Official Title:

Comparison of Intrafraction Motion in Patients with Head and Neck Cancer using Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking

Anticipated start date:

10/22/2009

Lead Sponsor:

Stanford University

Collaborator(s):

  • Varian Medical Systems

Investigator(s):

Study Type:

Interventional

Purpose:

Diagnostic

Allocation:

Non-randomized

Masking:

Open

Control:

Assignment:

Single Group

Endpoints:

N/A

Primary Outcomes:

  • We are measuring how much a patient moves during treatment.

Total Number to be Enrolled:

20

Total Number to be Enrolled at Stanford:

20

More Information

Trial Unique Id: SU-09082009-3800

Secondary ID(s):

  • ENT0028

Locations & Contacts

Stanford Locations & Contacts:

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Primary Contact:

Simon Wu (650) 725-8231

Non-Stanford Locations:

The Stanford website does not have any locations outside of Stanford listed for this trial. You may want to check clinicaltrials.gov for posible additional locations.

This listing was last updated:

10/30/2009

PLEASE NOTE:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician please feel free to call the SHC Physician Referral Service at (800) 756-9000 or send an email.

Stanford Medicine Resources:

Footer Links: